NURO Stock Performance ; Previous close, ; Day range, - ; Year range, 2 - 7 ; Market cap, 6,, ; Primary exchange, NASDAQ. Track Neurometrix Inc. (NURO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Stock Price Target NURO ; High · ; Median · ; Low · ; Average · ; Current Price · NURO Stock: 9 Things to Know About NeuroMetrix as Meme Stock Investors Send Shares Soaring NeuroMetrix (NURO) is rocketing higher on Friday as retail investors. NeuroMetrix, Inc. (NURO) ; Aug 19, , , , , ; Aug 16, , , , ,
Stock Price Targets ; High, $ ; Median, $ ; Low, $ ; Average, $ ; Current Price, $ Nuro is a robotics and autonomous vehicle technology company. Nuro manufactures custom autonomous delivery vehicles designed to drive in neighborhoods. NeuroMetrix Inc NURO:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/12/23 · 52 Week Low · 52 Week. NeuroMetrix (Nasdaq: NURO) has announced its upcoming second quarter business and financial highlights release, scheduled for August 6, , before the. The stock price for NeuroMetrix (NASDAQ: NURO) is $ and was last updated August 19, at AM EDT. Q. Does NeuroMetrix (NURO) pay a dividend? A. There. View NeuroMetrix, Inc. NURO stock quote prices, financial information, real-time forecasts, and company news from CNN. Discover real-time NeuroMetrix, Inc. Common Stock (NURO) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Why NeuroMetrix (NURO) Stock Is Soaring Today. NeuroMetrix (NURO) soared Tuesday after the FDA cleared the medical device company's wearable technology for over. A high-level overview of NeuroMetrix, Inc. (NURO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. NeuroMetrix Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, K ; Market Value, $M. NeuroMetrix Inc NURO ; Valuation · Price/Earnings (Normalized). —. Price/Book Value. Price/Sales. Price/Cash Flow ; Financial Strength · Quick Ratio.
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve. NeuroMetrix's stock soars in active trade after collaboration with GlaxoSmithKline on Quell. Shares of NeuroMetrix Inc. rocketed 78% toward a 7-month high. The current price of NURO is USD — it has decreased by −% in the past 24 hours. Watch NeuroMetrix, Inc. stock price performance more closely on the. NeuroMetrix Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NURO. The last closing price for NeuroMetrix was $ Over the. NeuroMetrix, Inc. (NURO): Price and Financial Metrics ; 5-year, % ; YTD, % ; , % ; , % ; , %. Webull offers Neurometrix Inc (NURO) historical stock prices, in-depth market analysis, NASDAQ: NURO real-time stock quote data, in-depth charts. Because Nuro is privately held, its stock is not available for purchase through public stock exchanges like the NYSE or Nasdaq. NeuroMetrix Inc (NURO) ; Open: ; Day's Range: ; 52 wk Range: ; Volume: 14, ; Average Vol. (3m): 14, Institutional Ownership and Shareholders. NeuroMetrix, Inc. (US:NURO) has 19 institutional owners and shareholders that have filed 13D/G or 13F forms with the.
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at apps30.ru They set a "sell" rating on the stock. Nuro has no public stock price. To access current and historical pricing information on Nuro stock, you can review filings from the company's past primary. Brainsway Ltd - ADR. $ BWAY % ; Neuropace Inc. $ NPCE % ; Stryker Corp. $ SYK % ; Ecora Resources PLC. GBX ECOR % ; Nevro. About NeuroMetrix Stock (NASDAQ:NURO) NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical. Find the latest historical data for NeuroMetrix, Inc. Common Stock (NURO) at apps30.ru View historical data in a monthly, bi-annual, or yearly format.
NURO Broker Recommendations Summary · The number of analysts covering the stock of NURO is greater than practically none of all US stocks. · The variance in.